Back

State-of-the-art lecture in lipid lowering therapy and the atheroma .

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Lipid-lowering therapy and the atheroma Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Stephen Nicholls

Monash University, Melbourne (Australia)

2 More presentations in this session

Presentation thumbnail
Longer-term safety of alirocumab with 24,610 patient-years of placebo-controlled observation: Further insights from the ODYSSEY OUTCOMES trial
Doctor S. Goodman (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Interrelation between baseline plaque characteristics and changes in coronary atherosclerosis with the PCSK9-inhibitor alirocumab: Insights from the PACMAN-AMI randomized trial
Doctor K. Koskinas (Bern, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Lipid-lowering therapy and the atheroma
Video

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Stepwise approach to lipid-lowering therapies: which one, when, and for whom?
thumbnail
Congress Presentation
Lipid control in cardiovascular patients
thumbnail
Congress Presentation
High-intensity lipid-lowering therapy accelerates early plaque regression: a FLOWPROMOTE sub study.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources